Secondary Pharmacology Targets for Pediatric Developmental Safety Assessment of New Drugs: Clinical Pharmacology Considerations.

Burckart GJ, Samuels S, Abdel-Rahman SM, Abulwerdi G, Fletcher E, Mohamoud MA, Srinivasan A, Tatonetti N, Racz R

DOI: 10.1002/cpt.70465
Published: 2026 Sep 3
Container: Clinical pharmacology and therapeutics
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1002/cpt.70465,
  title = {Secondary Pharmacology Targets for Pediatric Developmental Safety Assessment of New Drugs: Clinical Pharmacology Considerations.},
  author = {Burckart GJ and Samuels S and Abdel-Rahman SM and Abulwerdi G and Fletcher E and Mohamoud MA and Srinivasan A and Tatonetti N and Racz R},
  year = {2026},
  journal = {Clinical pharmacology and therapeutics},
  doi = {10.1002/cpt.70465},
  url = {https://doi.org/10.1002/cpt.70465}
}

RIS

TY  - JOUR
TI  - Secondary Pharmacology Targets for Pediatric Developmental Safety Assessment of New Drugs: Clinical Pharmacology Considerations.
AU  - Burckart GJ
AU  - Samuels S
AU  - Abdel-Rahman SM
AU  - Abulwerdi G
AU  - Fletcher E
AU  - Mohamoud MA
AU  - Srinivasan A
AU  - Tatonetti N
AU  - Racz R
PY  - 2026
JO  - Clinical pharmacology and therapeutics
DO  - 10.1002/cpt.70465
UR  - https://doi.org/10.1002/cpt.70465
ER  -

APA

GJ, B., S, S., SM, A., G, A., E, F., MA, M., A, S., N, T., & R, R. (2026). Secondary Pharmacology Targets for Pediatric Developmental Safety Assessment of New Drugs: Clinical Pharmacology Considerations.. Clinical pharmacology and therapeutics. https://doi.org/10.1002/cpt.70465

Source records

pubmed · retrieved 2026-09-25T20:14:20.169Z
europe-pmc · retrieved 2026-09-25T20:14:20.186Z